F-18-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients

B. A. W. Hoeben*, E. G. C. Troost, J. Bussink, C. M. L. van Herpen, W. J. G. Oyen, J. H. A. M. Kaanders

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)60-66
JournalNuklearmedizin
Volume53
Issue number2
DOIs
Publication statusPublished - 2014

Keywords

  • [F-18] fluorothymidine PET
  • head and neck cancer
  • cetuximab
  • radiotherapy
  • early response monitoring

Cite this